…value-based care.” “Value” is the key word: Companies will need to better adapt to the shift to a value-based system, part of which involves finding more effective ways to engage…
…value-based care.” “Value” is the key word: Companies will need to better adapt to the shift to a value-based system, part of which involves finding more effective ways to engage…
…leave the readers with just one takeaway. One: There is no such thing as minimum compliance. There is no such thing as maximum compliance. There is just compliance. In closing,…
…leave the readers with just one takeaway. One: There is no such thing as minimum compliance. There is no such thing as maximum compliance. There is just compliance. In closing,…
Device companies may also need to assess their product portfolios to provide a more comprehensive suite of tools, according to a new report….
Device companies may also need to assess their product portfolios to provide a more comprehensive suite of tools, according to a new report….
…amount of initial inhibitions in terms of its usability, app deployment and hardware, 2016 has seen it come to the forefront and become a mainstream technology. The global success of…
…amount of initial inhibitions in terms of its usability, app deployment and hardware, 2016 has seen it come to the forefront and become a mainstream technology. The global success of…
…Nanomix eLab system opens the door to many testing applications that can improve patient outcomes and potentially lower the cost of healthcare. While sepsis-related diagnostic tests are a first step,…
…Nanomix eLab system opens the door to many testing applications that can improve patient outcomes and potentially lower the cost of healthcare. While sepsis-related diagnostic tests are a first step,…
…conducted to pursue this path. One large opportunity in China’s device market is for Western device companies to increase their sourcing of commodity medtech components and finished products. Importing new…
…conducted to pursue this path. One large opportunity in China’s device market is for Western device companies to increase their sourcing of commodity medtech components and finished products. Importing new…
–UPDATE December, 13, 2016: Today President Obama signed the 21st Century Cures Act into law. FDA Commissioner Robert Califf, M.D. provided comments on the Act in FDA Voice (the agency’s…
–UPDATE December, 13, 2016: Today President Obama signed the 21st Century Cures Act into law. FDA Commissioner Robert Califf, M.D. provided comments on the Act in FDA Voice (the agency’s…
…management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA. (June 2016). Inspections, Compliance, Enforcement, and Criminal Investigations. General Medical Company. Accessed December 04, 2016. Retrieved from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2016/ucm508251.htm…
…management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA. (June 2016). Inspections, Compliance, Enforcement, and Criminal Investigations. General Medical Company. Accessed December 04, 2016. Retrieved from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2016/ucm508251.htm…
…You also want to define compliance persistence, adherence—that’s one of biggest challenges, too. Companies have to think about that comprehensive information value loop—meaning they’re really thinking about a solution rather…
…You also want to define compliance persistence, adherence—that’s one of biggest challenges, too. Companies have to think about that comprehensive information value loop—meaning they’re really thinking about a solution rather…
…combination products review program. “As technologies advance across multiple fields, the distinctions that previously allowed combination products to be neatly categorized by FDA’s medical product centers are blurring or even…
…combination products review program. “As technologies advance across multiple fields, the distinctions that previously allowed combination products to be neatly categorized by FDA’s medical product centers are blurring or even…
